Generic
Empagliflozin
Description
JARDIAN 10 is an oral antidiabetic medication produced by Beximco Pharmaceuticals Ltd. It contains Empagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor. This medication improves glycemic control in adults with type 2 diabetes mellitus and reduces the risk of cardiovascular death in those with existing cardiovascular disease.
Benefits
JARDIAN 10 aids in blood sugar control, promotes weight loss, reduces blood pressure, and lowers the risk of cardiovascular death in patients with type 2 diabetes and cardiovascular disease. It also improves kidney glucose excretion, effectively reducing hyperglycemia.
Ingredients
The active ingredient in Jardian 10 is Empagliflozin 10mg.
Uses and Doses
Jardian 10 is used to manage type 2 diabetes mellitus as an adjunct to diet and exercise. The recommended dose is 10 mg once daily, taken in the morning with or without food. The FThedose may be increased to 25 mg once daily. For patients tolerating the medication
Side Effects
Common side effects include urinary tract infections, female genital mycotic infections, dehydration, hypotension, increased thirst, weakness, and dizziness. Severe allergic reactions and disorientation are rare but possible.
How to Use
Take Jardian 10 orally once daily in the morning, with or without food. To avoid dehydration, ensure proper hydration. Follow the prescribed dose and instructions from your physician.
Pregnancy & Lactation
Empagliflozin should be used during pregnancy only if the potential benefit outweighs the risk to the fetus, as it has not been adequately studied in pregnant women. It is not recommended for breastfeeding mothers, as it is unclear whether the drug passes into breast milk.
Precautions and Warnings
JARDIAN 10 is not recommended for patients with severe renal impairment, end-stage renal disease, or those on dialysis. Use cautiously in patients with volume depletion, and assess renal function before and during treatment. Avoid use in breastfeeding mothers.
Safety Information
Store below 30°C in a cool, dry place protected from light and moisture. Keep it out of the reach of children and avoid using it a bit beyond the expiration date.
Indications
JARDIAN 10 is indicated for glycemic control in type 2 diabetes mellitus and for reducing cardiovascular death risk in adult patients with type 2 diabetes and cardiovascular disease.
Pharmacology
Empagliflozin works by inhibiting SGLT-2 in the kidney, which reduces renal glucose reabsorption, increases glucose excretion in urine, and lowers blood glucose levels. This mechanism also contributes to weight loss and reduced blood pressure.
Therapeutic Class
Sodium-glucose Co-transporter-2 (SGLT2) Inhibitors
Storage Conditions
Store in a cool, dry place below 30°C, away from light and moisture. Keep out of the reach of children.
3 FAQs
1. Can Jardian 10 be used in type 1 diabetes?
No, Jardin 10 is not indicated for type 1 diabetes mellitus.
2. Can Jardian 10 be taken with insulin?
Yes, but co-administration with insulin or insulin secretagogues increases the risk of hypoglycemia. Therefore, it is essential to monitor blood glucose levels carefully.
3. Does Jardian 10 affect kidney function?
Yes, it is contraindicated in patients with severe renal impairment, end-stage renal disease, or those on dialysis.
Disclaimer
This information is for educational purposes only and does not replace medical advice. Always consult a physician for proper diagnosis and treatment.
Keywords: Jardian 10, Empagliflozin 10mg, type 2 diabetes treatment, cardiovascular risk reduction, SGLT-2 inhibitor, blood glucose control, urinary glucose excretion, weight loss, glycemic control, antidiabetic medication, Jardian side effects, Empagliflozin benefits, Jardian uses, hyperglycemia management, type 2 diabetes management, Beximco Pharmaceuticals, diabetic medication, blood pressure reduction, renal glucose reabsorption inhibitor, Jardian dosage, Jardian precautions.
Additional information
Weight | 0.05 kg |
---|---|
Dimensions | 4 × 2 × 1 in |
Class -Dosage | Tablets |
Size | 10mg |
Generics | Empagliflozin |
pharmaceuticals | Beximco Pharmaceuticals Ltd. |
Reviews
There are no reviews yet.